Sign Up Today and Learn More About Abridge Stock
Invest in or calculate the value of your shares in Abridge or other pre-IPO companies through EquityZen's platform.
Abridge Stock (ABRI)
Abridge is a medical conversation AI startup that structures and summarizes medical conversations for doctors and patients.
About Abridge Stock
Founded
2018
Headquarters
Pittsburgh, PA, US
Industries
Software, Data and Analytics, Science and Engineering
Abridge Press Mentions
Stay in the know about the latest news on Abridge
Healthcare Moves: A Monthly Summary of Hires and Layoffs
medcitynews • Nov 29, 2024
Wolters Kluwer and Abridge Partner to Integrate UpToDate Trusted Physician-Authored Content in AI-Generated Clinical Documentation
businesswire • Oct 11, 2024
AI Gobbled A Record Share Of Startup Funding This Year
news • Sep 04, 2024
Kaiser Permanente rolls out Abridge's gen AI clinical tech across 40-hospital system
fiercehealthcare • Aug 15, 2024
Abridge partners with Epic, Mayo Clinic to create a genAI nurse workflow tool
mobihealthnews • Jul 24, 2024
Abridge Management
Leadership team at Abridge
Co-Founder, CEO
Shivdev Rao
COO
Julia Chou Chapin
Join now and verify your accreditation status to gain access to:
- Abridge current valuation
- Abridge stock price
- Available deals in Abridge and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Abridge Stock
How to invest in Abridge stock?
Accredited investors can buy pre-IPO stock in companies like Abridge through EquityZen funds. These investments are made available by existing Abridge shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Abridge stock?
Shareholders can sell their Abridge stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
